Jennison Associates LLC Uni Qure N.V. Transaction History

Jennison Associates LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 04, 2020	SELL	$35.98 - $47.66 $5.24 Million - $6.94 Million	-145,621 Closed	0 $0
Q2 2020 Aug 06, 2020	BUY	$45.06 - $67.74 $668,555 - $1.01 Million	14,837 Added 11.34%	145,621 $6.56 Million
Q1 2020 May 06, 2020	BUY	$40.01 - $73.97 $5.23 Million - $9.67 Million	130,784 New	130,784 $6.21 Million

142

35.3M

1.54M

389K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $300M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Jennison Associates LLC with notifications on news.